- Home
- ADCT vs PHD Comparison
ADCT vs PHD Comparison
Compare ADCT & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- PHD
- Stock Information
- Founded
- ADCT 2011
- PHD 2004
- Country
- ADCT Switzerland
- PHD United States
- Employees
- ADCT N/A
- PHD N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- PHD Investment Managers
- Sector
- ADCT Health Care
- PHD Finance
- Exchange
- ADCT Nasdaq
- PHD Nasdaq
- Market Cap
- ADCT 127.9M
- PHD 117.7M
- IPO Year
- ADCT 2020
- PHD N/A
- Fundamental
- Price
- ADCT $1.28
- PHD $9.71
- Analyst Decision
- ADCT Strong Buy
- PHD
- Analyst Count
- ADCT 5
- PHD 0
- Target Price
- ADCT $7.75
- PHD N/A
- AVG Volume (30 Days)
- ADCT 235.3K
- PHD 67.7K
- Earning Date
- ADCT 05-14-2025
- PHD 01-01-0001
- Dividend Yield
- ADCT N/A
- PHD 11.43%
- EPS Growth
- ADCT N/A
- PHD N/A
- EPS
- ADCT N/A
- PHD 1.27
- Revenue
- ADCT $70,837,000.00
- PHD N/A
- Revenue This Year
- ADCT $6.82
- PHD N/A
- Revenue Next Year
- ADCT $18.56
- PHD N/A
- P/E Ratio
- ADCT N/A
- PHD $7.60
- Revenue Growth
- ADCT 1.84
- PHD N/A
- 52 Week Low
- ADCT $1.05
- PHD $8.30
- 52 Week High
- ADCT $4.83
- PHD $9.81
- Technical
- Relative Strength Index (RSI)
- ADCT 43.00
- PHD 68.82
- Support Level
- ADCT $1.23
- PHD $9.29
- Resistance Level
- ADCT $1.49
- PHD $9.43
- Average True Range (ATR)
- ADCT 0.08
- PHD 0.10
- MACD
- ADCT 0.00
- PHD 0.04
- Stochastic Oscillator
- ADCT 25.00
- PHD 95.71
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About PHD Pioneer Floating Rate Fund Inc.
Pioneer Floating Rate Trust is a diversified, closed-end fund. Its investment objective is to provide a high level of current income and seek the preservation of capital by investing predominantly in floating-rate loans.